MNOV – Medicinova Inc
MNOV
$1.36Name : MediciNova, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $66,702,832.00
EPSttm : -0.23
MediciNova, Inc.
$1.36
Float Short %
0.41
Margin Of Safety %
Put/Call OI Ratio
0.06
EPS Next Q Diff
-0.06
EPS Last/This Y
-0.27
EPS This/Next Y
0.12
Price
1.46
Target Price
7.5
Analyst Recom
1
Performance Q
-20.65
Relative Volume
0.28
Beta
0.44
Ticker: MNOV
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-04-14 | MNOV | 1.44 | 0.12 | 0.00 | 564 |
2025-04-15 | MNOV | 1.41 | 0.11 | 0.00 | 574 |
2025-04-16 | MNOV | 1.44 | 0.11 | 0.00 | 574 |
2025-04-17 | MNOV | 1.45 | 0.11 | 999.99 | 584 |
2025-04-18 | MNOV | 1.45 | 0.11 | 999.99 | 584 |
2025-04-21 | MNOV | 1.47 | 0.11 | 999.99 | 584 |
2025-04-22 | MNOV | 1.48 | 0.26 | 999.99 | 39 |
2025-04-23 | MNOV | 1.49 | 0.29 | 0.00 | 40 |
2025-04-24 | MNOV | 1.51 | 0.22 | 0.00 | 50 |
2025-04-25 | MNOV | 1.56 | 0.12328767123288 | 0 | 82 |
2025-04-28 | MNOV | 1.5599 | 0.12328767123288 | 0 | 82 |
2025-04-29 | MNOV | 1.54 | 0.12 | 0.00 | 82 |
2025-04-30 | MNOV | 1.5799 | 0.12 | 0.00 | 82 |
2025-05-01 | MNOV | 1.51 | 0.12 | 0.00 | 82 |
2025-05-02 | MNOV | 1.52 | 0.12 | 0.00 | 82 |
2025-05-05 | MNOV | 1.5 | N/A | N/A | 0 |
2025-05-06 | MNOV | 1.52 | N/A | N/A | 0 |
2025-05-07 | MNOV | 1.54 | N/A | N/A | 0 |
2025-05-08 | MNOV | 1.49 | N/A | N/A | 0 |
2025-05-09 | MNOV | 1.48 | 0.07 | 0.00 | 140 |
2025-05-12 | MNOV | 1.44 | 0.07 | 0.00 | 140 |
2025-05-13 | MNOV | 1.4558 | 0.06 | 0.00 | 150 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-04-14 | MNOV | 1.40 | - | - | -0.50 |
2025-04-15 | MNOV | 1.40 | - | - | -0.50 |
2025-04-16 | MNOV | 1.42 | - | - | -0.50 |
2025-04-17 | MNOV | 1.45 | - | - | -0.50 |
2025-04-18 | MNOV | 1.45 | - | - | -0.50 |
2025-04-21 | MNOV | 1.47 | - | - | -0.50 |
2025-04-22 | MNOV | 1.50 | - | - | -0.50 |
2025-04-23 | MNOV | 1.49 | - | - | -0.50 |
2025-04-24 | MNOV | 1.52 | - | - | -0.50 |
2025-04-25 | MNOV | 1.56 | - | - | -0.50 |
2025-04-28 | MNOV | 1.56 | - | - | -0.50 |
2025-04-29 | MNOV | 1.59 | - | - | -0.50 |
2025-04-30 | MNOV | 1.52 | - | - | -0.50 |
2025-05-01 | MNOV | 1.47 | - | - | -0.50 |
2025-05-02 | MNOV | 1.51 | - | - | -0.50 |
2025-05-05 | MNOV | 1.50 | - | - | -0.50 |
2025-05-06 | MNOV | 1.49 | - | - | -0.50 |
2025-05-07 | MNOV | 1.49 | - | - | -0.50 |
2025-05-08 | MNOV | 1.49 | - | - | -0.50 |
2025-05-09 | MNOV | 1.47 | - | - | -0.50 |
2025-05-12 | MNOV | 1.44 | - | - | -0.50 |
2025-05-13 | MNOV | 1.46 | - | - | -0.50 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-04-14 | MNOV | 0.00 | 6.11 | 0.50 |
2025-04-15 | MNOV | 0.00 | 6.11 | 0.50 |
2025-04-16 | MNOV | 0.00 | 6.11 | 0.50 |
2025-04-17 | MNOV | 0.00 | 6.11 | 0.50 |
2025-04-18 | MNOV | 0.00 | 6.11 | 0.50 |
2025-04-21 | MNOV | 0.00 | 6.21 | 0.50 |
2025-04-22 | MNOV | 0.00 | 6.21 | 0.50 |
2025-04-23 | MNOV | 0.00 | 6.21 | 0.50 |
2025-04-24 | MNOV | 0.00 | 6.21 | 0.50 |
2025-04-25 | MNOV | 0.00 | 6.21 | 0.50 |
2025-04-28 | MNOV | 0.00 | 6.17 | 0.41 |
2025-04-29 | MNOV | 0.00 | 6.17 | 0.41 |
2025-04-30 | MNOV | 0.00 | 6.17 | 0.41 |
2025-05-01 | MNOV | 0.00 | 6.17 | 0.41 |
2025-05-02 | MNOV | 0.00 | 6.17 | 0.41 |
2025-05-05 | MNOV | 0.00 | 6.08 | 0.41 |
2025-05-06 | MNOV | 0.00 | 6.08 | 0.41 |
2025-05-07 | MNOV | 0.00 | 6.08 | 0.41 |
2025-05-08 | MNOV | 0.00 | 6.08 | 0.41 |
2025-05-09 | MNOV | 0.00 | 6.08 | 0.41 |
2025-05-12 | MNOV | 0.00 | 3.56 | 0.41 |
2025-05-13 | MNOV | 0.00 | 3.56 | 0.41 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.12
Insider Transactions
Institutional Transactions
3.56
Beta
0.44
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
21
Sentiment Score
14
Actual DrawDown %
89
Max Drawdown 5-Year %
-89.7
Target Price
7.5
P/E
Forward P/E
PEG
P/S
P/B
1.36
P/Free Cash Flow
EPS
-0.23
Average EPS Est. Cur. Y
-0.5
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.28
Return on Equity vs Sector %
-44.7
Return on Equity vs Industry %
-27.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading